Neubase Therapeutics Inc. buy elfe
Start price
31.01.15
/
50%
€2,596.8
Target price
01.06.15
€4,800.0
Performance (%)
-64.20%
End price
01.06.15
€929.60
Summary
This prediction ended on 01.06.15 with a price of €929.60. Massive losses of -64.20% were the result for the BUY prediction by elfe. elfe has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neubase Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1,34 % | -5,62 % | 3,38 % | 51,20 % |
| iShares Nasdaq 100 | -1,07 % | 2,60 % | 19,13 % | 93,73 % |
| iShares Nikkei 225® | -1,99 % | -6,51 % | 27,85 % | 51,19 % |
| iShares S&P 500 | -1,32 % | 0,91 % | 14,19 % | 65,29 % |
Comments by elfe for this prediction
In the thread NeuBase Therapeutics Inc. diskutieren
Neue Wege und klare Lösungen, Ohr Pharmaceutical auf dem weg neuartige Therapien zu finden.
Marktplazierung: 172,85 Millionen Euro
Anzahl der Aktien: 25,39 Millionen
Kaufsignal
(Vom Mitglied beendet)